Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular and mucous membranes are fundamental biological barriers that separate internal physiological environments from external stressors (Nature Education, 2014). Cellular membranes consist of phospholipid bilayers with embedded proteins that facilitate transport and signaling, while mucous membranes (mucosae) are specialized epithelial layers that secrete protective mucus to line internal tracts such as the respiratory and gastrointestinal systems (StatPearls, 2023). These structures are not individual molecular targets but rather complex tissues that serve as the site of action for various pharmacological agents (NIH, 2022). For instance, local anesthetics like lidocaine exert their effect by stabilizing these membranes and inhibiting ion channel activity, while many antimicrobial agents, such as amphotericin B, work by directly binding to and disrupting the integrity of fungal cell membranes (PubMed, 2021; PubChem, 2024). Pathological conditions like mucositis, infections, and mechanical trauma can compromise these barriers, leading to significant clinical complications (StatPearls, 2023). In drug development, the permeability and integrity of these membranes are primary factors in determining the bioavailability and delivery route of therapeutic compounds.
Drugs interacting with these structures typically act by modulating membrane permeability, providing physical protection/lubrication, or inhibiting ion channels and receptors embedded within the lipid bilayer to achieve local anesthesia or antimicrobial effects.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular and mucous membranes.